Partner Perspectives | TrialCard Inc.

Hubs can be the secret weapon to providing customized solutions to the industry-wide challenge of improving patient outcomes.

As competition in a diversifying specialty drug business rises to fiver pitch, manufacturers are seeking new ways to differentiate the product servicing model to help their brands stand out. Triplefin's Hub-Lite™ program is adapting to these new expectations with a customized set of services geared to specialty's biggest growth segment: mid-range therapies with higher price tags than traditional retail pharmacy but significantly lower than high-end specialty pharma.

Transitioning Hub programs is daunting. But making a major change can be a necessary step to foster a brand's performance through improved patient support services. At CBI's 6th Annual Hub and SPP Model Optimization Conference in Philadelphia this February, Scott Dulitz of Trialcard outlines key points of consideration and best practices to fast track the switch to move forward once you've come to the conclusion that a change is necessary.

How do you really know if your co-pay program is working? Figuring ROI seems straightforward. But Paul LeVine, Vice President of Analytic Services for TrialCard Market Access Solutions thinks the calculus might require a deeper look than is traditionally given as he explained at the 2nd Annual Coupon and Co-Pay Strategy Summit in Philadelphia in February.